Midamor and Weakness - a phase IV clinical study of FDA data

Summary:

Weakness is reported as a side effect among people who take Midamor (amiloride hydrochloride), especially for people who are male, 60+ old, also take Pantoprazole, and have High blood pressure.

The phase IV clinical study analyzes which people have Weakness when taking Midamor. It is created by eHealthMe based on reports of 342 people who have side effects when taking Midamor from the FDA, and is updated regularly.

What is Midamor?

Midamor has active ingredients of amiloride hydrochloride. eHealthMe is studying from 348 Midamor users. Check the latest studies of Midamor.

What is Weakness?

Weakness is found to be associated with 3,638 drugs and 6,618 conditions by eHealthMe. Check the latest studies of Weakness.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

342 people reported to have side effects when taking Midamor.
Among them, 26 people (7.6%) have Weakness.

Among these 26 people:

What is the gender of people who have Weakness when taking Midamor? *

female: 50 %
male: 50 %

What is the age of people who have Weakness when taking Midamor? *

What are other drugs people take besides Midamor? *

What are other side effects people have besides Weakness? *

Dyspnea (difficult or laboured breathing): 12 people, 46.15%
Weight Decreased: 9 people, 34.62%
Abdominal Pain: 9 people, 34.62%
Cardiac Failure Congestive: 9 people, 34.62%
Skin Discoloration - Bluish (bluish colour of skin): 8 people, 30.77%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 8 people, 30.77%
Peripheral Swelling: 8 people, 30.77%
Coronary Artery Occlusion (complete obstruction of blood flow in a coronary artery): 8 people, 30.77%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 8 people, 30.77%
Drug Intolerance (drug sensitivity): 7 people, 26.92%

What are the existing conditions these people have? *

High Blood Pressure: 11 people, 42.31%
Stress And Anxiety: 9 people, 34.62%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 8 people, 30.77%
Cardiac Disorder: 7 people, 26.92%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 3 people, 11.54%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 11.54%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 3 people, 11.54%
Neuralgia (pain in one or more nerves): 2 people, 7.69%
Pain: 2 people, 7.69%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Midamor and have Weakness?

- Check whether Weakness is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Midamor:

Midamor (348 reports)

Weakness treatments and more:

Weakness (586,877 reports)

Browse all side effects of Midamor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Weakness:

Weakness (3,638 drugs)

Browse all the conditions that are associated with Weakness:

Weakness (6,618 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on amiloride hydrochloride (the active ingredients of Midamor) and Midamor (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.